These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20595149)

  • 1. Bosentan does not improve pulmonary hypertension and lung remodeling in heart failure.
    Jiang BH; Tardif JC; Shi Y; Dupuis J
    Eur Respir J; 2011 Mar; 37(3):578-86. PubMed ID: 20595149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bosentan effects on hemodynamics and clinical outcome in heart failure patients with pulmonary hypertension awaiting cardiac transplantation.
    Hefke T; Zittermann A; Fuchs U; Schulte-Eistrup S; Gummert JF; Schulz U
    Thorac Cardiovasc Surg; 2012 Feb; 60(1):26-34. PubMed ID: 21432755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
    Nguyen QT; Nsaibia MJ; Sirois MG; Calderone A; Tardif JC; Fen Shi Y; Ruiz M; Daneault C; Gagnon L; Grouix B; Laurin P; Dupuis J
    Cardiovasc Res; 2020 Jan; 116(1):171-182. PubMed ID: 30753422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasudil reduces monocrotaline-induced pulmonary arterial hypertension: comparison with bosentan and sildenafil.
    Mouchaers KT; Schalij I; de Boer MA; Postmus PE; van Hinsbergh VW; van Nieuw Amerongen GP; Vonk Noordegraaf A; van der Laarse WJ
    Eur Respir J; 2010 Oct; 36(4):800-7. PubMed ID: 20351034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The remodeling of connexin in the hypertrophied right ventricular in pulmonary arterial hypertension and the effect of a dual ET receptor antagonist (bosentan).
    Tan XY; He JG
    Pathol Res Pract; 2009; 205(7):473-82. PubMed ID: 19232841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the oral endothelin-receptor antagonist bosentan on echocardiographic and doppler measures in patients with pulmonary arterial hypertension.
    Galiè N; Hinderliter AL; Torbicki A; Fourme T; Simonneau G; Pulido T; Espinola-Zavaleta N; Rocchi G; Manes A; Frantz R; Kurzyna M; Nagueh SF; Barst R; Channick R; Dujardin K; Kronenberg A; Leconte I; Rainisio M; Rubin L
    J Am Coll Cardiol; 2003 Apr; 41(8):1380-6. PubMed ID: 12706935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure.
    Chabot A; Jiang BH; Shi Y; Tardif JC; Dupuis J
    BMC Cardiovasc Disord; 2011 Dec; 11():72. PubMed ID: 22136321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of echocardiographic variables of right ventricular function with exercise capacity after bosentan treatment in patients with pulmonary arterial hypertension: Results from a multicenter, prospective, cohort study.
    Kim H; Bae Lee J; Park JH; Yoo BS; Son JW; Yang DH; Lee BR
    J Clin Ultrasound; 2017 Jan; 45(1):28-34. PubMed ID: 27619758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic endothelin receptor blockade attenuates progressive ventricular dilation and improves cardiac function in rats with myocardial infarction: possible involvement of myocardial endothelin system in ventricular remodeling.
    Fraccarollo D; Hu K; Galuppo P; Gaudron P; Ertl G
    Circulation; 1997 Dec; 96(11):3963-73. PubMed ID: 9403621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of Macitentan and Bosentan on Right Ventricular Remodeling in a Rat Model of Non-vasoreactive Pulmonary Hypertension.
    Iglarz M; Landskroner K; Bauer Y; Vercauteren M; Rey M; Renault B; Studer R; Vezzali E; Freti D; Hadana H; Schläpfer M; Cattaneo C; Bortolamiol C; Weber E; Whitby BR; Delahaye S; Wanner D; Steiner P; Nayler O; Hess P; Clozel M
    J Cardiovasc Pharmacol; 2015 Nov; 66(5):457-67. PubMed ID: 26230396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bosentan, sildenafil, and their combination in the monocrotaline model of pulmonary hypertension in rats.
    Clozel M; Hess P; Rey M; Iglarz M; Binkert C; Qiu C
    Exp Biol Med (Maywood); 2006 Jun; 231(6):967-73. PubMed ID: 16741032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.
    Sanganalmath SK; Barta J; Takeda N; Kumamoto H; Dhalla NS
    Can J Physiol Pharmacol; 2008 Apr; 86(4):180-9. PubMed ID: 18418427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective and unselective endothelin-receptor antagonists on prostacyclin synthase gene expression in experimental pulmonary hypertension.
    Schroll S; Arzt M; Sebah D; Stoelcker B; Luchner A; Budweiser S; Blumberg FC; Pfeifer M
    Scand J Clin Lab Invest; 2008; 68(4):270-6. PubMed ID: 18612919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling.
    Mulder P; Richard V; Derumeaux G; Hogie M; Henry JP; Lallemand F; Compagnon P; Macé B; Comoy E; Letac B; Thuillez C
    Circulation; 1997 Sep; 96(6):1976-82. PubMed ID: 9323089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem-cell therapy in an experimental model of pulmonary hypertension and right heart failure: role of paracrine and neurohormonal milieu in the remodeling process.
    Angelini A; Castellani C; Ravara B; Franzin C; Pozzobon M; Tavano R; Libera LD; Papini E; Vettor R; De Coppi P; Thiene G; Vescovo G
    J Heart Lung Transplant; 2011 Nov; 30(11):1281-93. PubMed ID: 21989772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single measurement of troponin T for early prediction of infarct size, congestive heart failure, and pulmonary hypertension in an animal model of myocardial infarction.
    Jiang BH; Nguyen QT; Tardif JC; Shi Y; Dupuis J
    Cardiovasc Pathol; 2011; 20(3):e85-9. PubMed ID: 20537565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular oxygen supply parameters are decreased in human and experimental pulmonary hypertension.
    Ruiter G; Ying Wong Y; de Man FS; Louis Handoko M; Jaspers RT; Postmus PE; Westerhof N; Niessen HW; van der Laarse WJ; Vonk-Noordegraaf A
    J Heart Lung Transplant; 2013 Feb; 32(2):231-40. PubMed ID: 23142560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biventricular structural and functional responses to aortic constriction in a rabbit model of chronic right ventricular pressure overload.
    Apitz C; Honjo O; Humpl T; Li J; Assad RS; Cho MY; Hong J; Friedberg MK; Redington AN
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1494-501. PubMed ID: 22818124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bosentan for treatment of heart failure].
    Yoshimoto T; Hirata Y
    Nihon Rinsho; 2007 May; 65 Suppl 5():159-63. PubMed ID: 17571378
    [No Abstract]   [Full Text] [Related]  

  • 20. Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
    Gosal K; Dunlop K; Dhaliwal R; Ivanovska J; Kantores C; Desjardins JF; Connelly KA; McNamara PJ; Jain A; Jankov RP
    Am J Respir Cell Mol Biol; 2015 Jun; 52(6):717-27. PubMed ID: 25337652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.